↑ トップへ　← 戻る

96. クローン病
［臨床試験数：2,209，薬物数：1,276（DrugBank：240），標的遺伝子数：166，標的パスウェイ数：210］

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
10 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03477032
(ClinicalTrials.gov)		June 1, 201819/3/2018FMT in Inflammatory Bowel DiseaseFaecal Transplantation in Inflammatory Bowel DiseaseFaecal Microbiota Transplantation;Crohn Disease;Ulcerative Colitis;Microscopic ColitisBiological: Faecal Microbiota TransplantationSt Vincent's Hospital MelbourneNULLRecruiting18 Years65 YearsAll50Australia
2NCT03194529
(ClinicalTrials.gov)		October 9, 201719/6/2017FMT in Pediatric Crohn's DiseaseSafety of FMT in Maintenance of Pediatric Crohn's DiseaseCrohn Disease;Pediatric Crohns DiseaseBiological: FMTChildren's Hospital Los AngelesNULLCompleted7 Years21 YearsAll9Phase 1;Phase 2United States
3NCT02330211
(ClinicalTrials.gov)		July 17, 201729/12/2014Fecal Microbiota Transplant (FMT) in Pediatric Active Crohn's ColitisA Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Crohn's ColitisInflammatory Bowel Diseases;Crohn DiseaseBiological: Fecal Microbiota Transplant;Biological: PlaceboStacy A. KahnNULLCompleted5 Years30 YearsAll4Phase 1;Phase 2United States
4NCT03078803
(ClinicalTrials.gov)		March 28, 201712/1/2017Fecal Transplant for Crohn's DiseaseA Prospective Multicenter Randomized Controlled Trial Comparing Fecal Microbiota Transplantation (FMT) to Placebo in the Treatment of Mild to Moderate Crohn's DiseaseCrohn DiseaseBiological: Fecal Microbiota Transplant (FMT);Biological: PlaceboUniversity of AlbertaUniversity of Calgary;McMaster UniversityRecruiting18 YearsN/AAll126Phase 2Canada
5JPRN-jRCTs031180415
01/02/201722/03/2019A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel diseaseSingle center non-randomized study: A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel disease Inflammatory Bowel Disease (Ulcerative Colitis, Crohn's Disease)
Inflammatory Bowel Disease (Ulcerative Colitis, Crohn's Disease)		AFM therapy arm : three antibiotics, amoxicillin (1500 mg/day), fosfomycin (3000 mg/day) and metronidazole (750 mg/day) are administered orally to patients for 2 weeks. For pediatric patients, amoxicillin (50mg/kg), fosfomycin (120mg/kg) and metronidazole (20mg/kg) are administered orally for 2 weeks (the upper limit is the same amount as adults).
FMT arm : Approximately 150 to 250 g of donor stool is diluted with saline (500 mL) and filtered to remove crude components. The diluted and filtered fecal suspension is transferred into the patients colon from cecum to rectum during total colonoscopy. As usual examinations, the patient undergoes biopsy of inflammatory site.
A-FMT arm : Patient undergoes FMT two days after AFM therapy.		Ishikawa DaiNULLRecruiting>= 6age oldNot applicableBoth120N/AJapan
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
6NCT02330653
(ClinicalTrials.gov)		November 201529/12/2014Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's ColitisA Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Ulcerative Colitis and Pediatric Active Crohn's ColitisInflammatory Bowel Diseases;Ulcerative Colitis;Crohn DiseaseBiological: Fecal Microbiota Transplant (FMT);Biological: PlaceboStacy A. KahnNULLCompleted5 Years30 YearsAll15Phase 1;Phase 2United States
7NCT02417974
(ClinicalTrials.gov)		September 20151/4/2015Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)Crohn's DiseaseBiological: Fecal Microbiota Transplant (FMT)Boston Medical CenterBrigham and Women's Hospital;Beth Israel Deaconess Medical Center;Massachusetts Institute of TechnologySuspended18 YearsN/AAll44Phase 2United States
8NCT02335281
(ClinicalTrials.gov)		January 20157/1/2015Standardized Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseEfficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflammatory Bowel DiseaseInflammatory Bowel Disease;Ulcerative Colitis;Crohn's DiseaseProcedure: FMT;Drug: MesalazineYanling WeiNULLRecruiting16 Years70 YearsBoth40Phase 2China
9NCT02108821
(ClinicalTrials.gov)		September 201421/3/2014Fecal Microbiota Transplantation in Pediatric PatientsA Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.Inflammatory Bowel Diseases (IBD);Crohn's Disease (CD);Ulcerative Colitis (UC)Biological: Fecal Microbiota Transplantation (FMT)Children's Mercy Hospital Kansas CityUniversity of PittsburghCompleted2 Years22 YearsAll23Phase 1United States
10NCT02199561
(ClinicalTrials.gov)		July 201422/7/2014Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's DiseaseA Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's DiseaseCrohn's DiseaseBiological: Fecal Microbiota TransplantUniversity of AlbertaNULLCompleted18 Years65 YearsBoth3Phase 1;Phase 2Canada

先頭へ